PET/MR scan
PET/MR scan is an intervention with 9 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 2 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Highest Phase Reached
UnknownTrial Status & Enrollment
100.0%
2 of 2 finished
0.0%
0 ended early
1
trials recruiting
9
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
The Sleep Amyloid, Slow WAve Race and Ethnicity Study
Energetics and Glutamate in Schizophrenia
Validation of PET-MRI for Cardiovascular Disease
Applying PET/MR in Oncology - a Prospective Project
Combination of 68Ga-PSMA PET Data With Magnetic Resonance Spectroscopy Data (MRS) for Evaluating Prostate Cancer
Clinical Trials (9)
The Sleep Amyloid, Slow WAve Race and Ethnicity Study
Energetics and Glutamate in Schizophrenia
Validation of PET-MRI for Cardiovascular Disease
Applying PET/MR in Oncology - a Prospective Project
Combination of 68Ga-PSMA PET Data With Magnetic Resonance Spectroscopy Data (MRS) for Evaluating Prostate Cancer
Non-invasive Evaluation of Lymphoma Patients Based on Artificial Intelligence and PET/MRI
Developing a Method Using PET-MR to Improve Staging and Monitoring of Neuroendocrine Tumor
Applying PET/MR in Neuroendocrine Tumors - Imaging Dynamic Processes in Both Modalities
Applying PET/MR in Rectal Cancer.
All 9 trials loaded
Drug Details
- Intervention Type
- DIAGNOSTIC TEST
- Total Trials
- 9